The use of the triangular test with response-adaptive treatment allocation
- PMID: 15706635
- DOI: 10.1002/sim.2051
The use of the triangular test with response-adaptive treatment allocation
Abstract
A clinical trial is considered in which two treatments with binary responses are to be compared. A popular sequential stopping rule, the triangular test, is studied when various response-adaptive treatment allocation rules are applied, such as the recently proposed drop-the-loser rule, an urn randomization scheme. The paper extends previous work by Coad and Rosenberger, who combined the triangular test with the randomized play-the-winner rule. The purpose of the paper is to investigate to what extent the variability of an adaptive design affects the overall performance of the triangular test. The adaptive rules under consideration are described and some of their asymptotic properties are summarized. Simulation is then used to assess the performance of the triangular test when combined with the various adaptive rules. The main finding is that the drop-the-loser rule is the most promising of the adaptive rules considered in terms of a less variable allocation proportion and a smaller number of treatment failures. The use of this rule with the triangular test is beneficial compared with the triangular test with equal allocation, since it yields fewer treatment failures on average while providing comparable power with similar expected sample size. The results of an AIDS trial are used to illustrate the performance of the triangular test when combined with the drop-the-loser rule.
Similar articles
-
A comparison of adaptive allocation rules for group-sequential binary response clinical trials.Stat Med. 2007 Apr 30;26(9):1937-54. doi: 10.1002/sim.2693. Stat Med. 2007. PMID: 16981177
-
Sequential urn designs with elimination for comparing K > or =3 treatments.Stat Med. 2005 Jul 15;24(13):1995-2009. doi: 10.1002/sim.2091. Stat Med. 2005. PMID: 15803441
-
Response adaptive designs with a variance-penalized criterion.Biom J. 2009 Oct;51(5):763-73. doi: 10.1002/bimj.200800233. Biom J. 2009. PMID: 19757432
-
Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.Antivir Ther. 2005;10(1):13-28. Antivir Ther. 2005. PMID: 15751760 Review.
-
Estimation following group-sequential response-adaptive clinical trials.Control Clin Trials. 2003 Oct;24(5):523-43. doi: 10.1016/s0197-2456(03)00062-x. Control Clin Trials. 2003. PMID: 14500051 Review.
Cited by
-
Clinical trials of drugs used off-label in neonates: ethical issues and alternative study designs.Account Res. 2008 Jul-Sep;15(3):168-87. doi: 10.1080/08989620802194392. Account Res. 2008. PMID: 18792537 Free PMC article.
-
Rethinking Phase II Clinical Trial Design in Heart Failure.Clin Investig (Lond). 2013 Jan 1;3(1):57-68. doi: 10.4155/cli.12.133. Clin Investig (Lond). 2013. PMID: 25343020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical